.
Blockade of the KOP receptor antagonist nor-binaltorphimine on the inhibitory effects of dynorphin A(1-17) against intrathecal β-endorphin-elicited scratching responses in monkeys. Dynorphin A (100 nmol) was given intrathecally in combination with β-endorphin (100 nmol). Inhibitory effects of dynorphin A on β-endorphin-elicited scratching were studied 10 days before and 1 day after intramuscular administration of nor-binaltorphimine 3 mg/kg. Each value represents mean ± S.E.M. (n=4). Symbols represent different dosing conditions for the same monkeys. Asterisk represents a significant difference between conditions with or without nor-binaltorphimine treatment at corresponding time point (p<0.05).
SI Methods

Procedures
Itch Scratching Responses
Recording was conducted in 15-min intervals for 2-3 hours after subjects received intrathecal administration of neuropeptides, and scored by individuals who were blinded to experimental conditions. A scratch was defined as one brief scraping contact of the forepaw or hind paw on the skin surface area above the shoulder (defined as head scratches, i.e., dermatomes corresponding to cervical nerves C1-C4 and trigeminal nerves) or the area below the shoulder (defined as body scratches, i.e., skin dermatomes corresponding to cervical nerves C5-C8, all thoracic, lumbar and sacral nerves) 
Nociceptive Responses
To produce inflammation-associated hyperalgesia, carrageenan (2 mg/tail in 0.1 mL of saline) was injected subcutaneously in the terminal 5 cm of the monkey's tail. sessions were analyzed by one-way ANOVA followed by the Dunnett test for multiple comparisons. The criterion for significance for all tests was set at p < 0.05.
